TG Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TG Therapeutics, Inc. on January 21, 2015. The report addresses Item 8.01 (Other Events) regarding the company's disclosure practices.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report does not contain financial statements or performance metrics.
Material Changes
There are no material changes to financial performance or operations reported in this filing. The document solely announces a potential change in communication channels.
Guidance, Outlook, and Management Commentary
Management notified investors that, in compliance with SEC guidance, the company may use social media to announce material information in the future. Investors are encouraged to monitor the following channels:
- TG Therapeutics Facebook Page
- TG Therapeutics Twitter Feed
Updates to the list of social media channels will be posted on the company's official website.
Key Facts for Investor Verification
- Verify the company's official social media handles on the corporate website to ensure authenticity.
- Confirm that material information is not being disseminated exclusively through unofficial channels.
- Note that this filing contains no financial data or operational updates beyond the communication policy notice.